Your browser doesn't support javascript.
loading
Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial.
Kalantzi, Kallirroi I; Ntalas, Ioannis V; Chantzichristos, Vasileios G; Tsoumani, Maria E; Adamopoulos, Dimitrios; Asimakopoulos, Christos; Bourdakis, Adamantios; Darmanis, Petros; Dimitriadou, Alexandra; Gkiokas, Stefanos; Ipeirotis, Konstantinos; Kitikidou, Kyriaki; Klonaris, Ioannis; Kostaki, Aglaia; Logothetis, Dimitrios; Mainas, Konstantinos; Mais, Theodoros; Maragiannis, Athanasios; Martiadou, Konstantina; Mavronasos, Konstantinos; Michelongonas, Ioannis; Mitropoulos, Dimitrios; Papadimitriou, Georgios; Papadopoulos, Achilleas; Papaioakeim, Miltiadis; Sofillas, Kosmas; Stabola, Sotiria; Stefanakis, Emmanouil; Stergiou, Dimitrios; Thoma, Maria; Zenetos, Alexandros; Zisekas, Stergios; Goudevenos, John A; Panagiotakos, Demosthenes B; Tselepis, Alexandros D.
Afiliação
  • Kalantzi KI; Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.
  • Ntalas IV; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Chantzichristos VG; Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.
  • Tsoumani ME; Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Adamopoulos D; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Asimakopoulos C; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Bourdakis A; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Darmanis P; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Dimitriadou A; Internal Medicine, Diabetes and Metabolism Unit, Trikala General Hospital, Trikala, Greece.
  • Gkiokas S; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Ipeirotis K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Kitikidou K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Klonaris I; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Kostaki A; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Logothetis D; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Mainas K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Mais T; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Maragiannis A; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Martiadou K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Mavronasos K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Michelongonas I; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Mitropoulos D; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Papadimitriou G; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Papadopoulos A; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Papaioakeim M; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Sofillas K; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Stabola S; Department of Internal Medicine, General Hospital of Komotini, Komotini, Greece.
  • Stefanakis E; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Stergiou D; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Thoma M; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Zenetos A; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Zisekas S; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Goudevenos JA; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Panagiotakos DB; Department of Chemistry, Atherothrombosis Research Centre, University of Ioannina, Ioannina, Greece.
  • Tselepis AD; Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.
Curr Vasc Pharmacol ; 17(6): 635-643, 2019.
Article em En | MEDLINE | ID: mdl-29866011
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Isquemia Encefálica / Salicilatos / Aspirina / Inibidores de Ciclo-Oxigenase / Acidente Vascular Cerebral / Embolia Intracraniana / Prevenção Secundária / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Isquemia Encefálica / Salicilatos / Aspirina / Inibidores de Ciclo-Oxigenase / Acidente Vascular Cerebral / Embolia Intracraniana / Prevenção Secundária / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article